{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:46:30Z","timestamp":1793357190164,"version":"4.5.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare disorder caused by severe ADAMTS13 deficiency. Major morbidities and death at a young age are common. Although replacement of ADAMTS13 can prevent morbidities and death, current regimens of plasma prophylaxis are insufficient. We identified 226 patients with hTTP in 96 reports published from 2001 through 2020. Age at diagnosis was reported for 202 patients; 117 were female and 85 were male. The difference was caused by diagnosis of 34 women during pregnancy, suggesting that many men and nulliparous women are not diagnosed. Eighty-three patients had severe jaundice at birth; hTTP was suspected and effectively treated in only 3 infants. Of the 217 patients who survived infancy, 73 (34%) had major morbidities defined as stroke, kidney injury, or cardiac injury that occurred at a median age of 21 years. Sixty-two patients had stroke; 13 strokes occurred in children age 10 years or younger. Of the 54 patients who survived their initial major morbidity and were subsequently observed, 37 (69%) had sustained or subsequent major morbidities. Of the 39 patients who were observed after age 40 years, 20 (51%) had experienced a major morbidity. Compared with an age- and sex-matched US population, probability of survival was lower at all ages beginning at birth. Prophylaxis was initiated in 45 patients with a major morbidity; in 11 (28%), a major morbidity recurred after prophylaxis had begun. Increased recognition of hTTP and more effective prophylaxis started at a younger age are required to improve health outcomes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005760","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T16:01:21Z","timestamp":1637596881000},"page":"750-759","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura"],"prefix":"10.1182","volume":"6","author":[{"given":"Azra","family":"Borogovac","sequence":"first","affiliation":[{"name":"Hematology-Oncology Section, Department of Medicine, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Reese","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Hematology-Oncology Section, Department of Medicine, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"George","sequence":"additional","affiliation":[{"name":"Hematology-Oncology Section, Department of Medicine, College of Medicine, and"},{"name":"Department of Biostatistics & Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"17","key":"2022012716232835400_B1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMra1813013","article-title":"Hereditary thrombotic thrombocytopenic purpura","volume":"381","author":"Kremer Hovinga","year":"2019","journal-title":"N Engl J Med."},{"issue":"5","key":"2022012716232835400_B2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0002-9343(75)90510-0","article-title":"Thrombotic thrombocytopenic purpura in four siblings","volume":"58","author":"Wallace","year":"1975","journal-title":"Am J Med."},{"issue":"19","key":"2022012716232835400_B3","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.1976.03260450038030","article-title":"Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters","volume":"235","author":"Fuchs","year":"1976","journal-title":"JAMA."},{"issue":"25","key":"2022012716232835400_B4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","article-title":"Treatment of thrombotic thrombocytopenic purpura with plasma","volume":"297","author":"Byrnes","year":"1977","journal-title":"N Engl J Med."},{"issue":"22","key":"2022012716232835400_B5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med."},{"issue":"22","key":"2022012716232835400_B6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med."},{"issue":"6855","key":"2022012716232835400_B7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature."},{"key":"2022012716232835400_B8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","article-title":"Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan","volume":"9","author":"Fujimura","year":"2011","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2022012716232835400_B9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol."},{"issue":"15","key":"2022012716232835400_B10","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","article-title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","volume":"133","author":"Alwan","year":"2019","journal-title":"Blood."},{"issue":"10","key":"2022012716232835400_B11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","volume":"104","author":"van Dorland","year":"2019","journal-title":"Haematologica."},{"issue":"23","key":"2022012716232835400_B12","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1182\/bloodadvances.2019000959","article-title":"Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia","volume":"3","author":"Borogovac","year":"2019","journal-title":"Blood Adv."},{"issue":"6","key":"2022012716232835400_B13","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","article-title":"Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke."},{"issue":"6","key":"2022012716232835400_B14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00134-017-4809-x","article-title":"Renal recovery after acute kidney injury","volume":"43","author":"Forni","year":"2017","journal-title":"Intensive Care Med."},{"key":"2022012716232835400_B15","article-title":"Life expectancy and healthy life expectancy, data by country","author":"World Health Organization","year":"2020"},{"issue":"1","key":"2022012716232835400_B16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jog.12125","article-title":"Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancy","volume":"40","author":"Tanaka","year":"2014","journal-title":"J Obstet Gynaecol Res."},{"issue":"4","key":"2022012716232835400_B17","first-page":"709","article-title":"Genetic and functional characterization of ADAMTS13 variants in a patient cohort of Upshaw-Schulman syndrome investigated in Germany","volume":"118","author":"Hassenpflug","year":"2018","journal-title":"Thromb Haemost."},{"issue":"4","key":"2022012716232835400_B18","first-page":"677","article-title":"Neonate with congenital thrombotic thrombocytopenic purpura: a case report of a de novo compound heterozygote mutation in ADAMTS13 gene and review of literature","volume":"66","author":"Lv","year":"2020","journal-title":"Clin Lab."},{"issue":"12","key":"2022012716232835400_B19","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3109\/14767058.2015.1071789","article-title":"Congenital thrombotic thrombocytopenic purpura: Upshaw-Schulman syndrome: a cause of neonatal death and review of literature","volume":"29","author":"Sharma","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"14","key":"2022012716232835400_B20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2018-01-827063","article-title":"A neonate presenting with jaundice, anemia, and thrombocytopenia","volume":"131","author":"Hager","year":"2018","journal-title":"Blood."},{"issue":"6","key":"2022012716232835400_B21","doi-asserted-by":"crossref","first-page":"e20161565","DOI":"10.1542\/peds.2016-1565","article-title":"Severe hemolysis and pulmonary hypertension in a neonate with Upshaw-Schulman syndrome","volume":"138","author":"Tsujii","year":"2016","journal-title":"Pediatrics."},{"issue":"1","key":"2022012716232835400_B22","first-page":"39","article-title":"Inherited thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) as differential diagnosis to neonatal septicaemia with disseminated intravascular coagulation - a case series","volume":"221","author":"Lehmberg","year":"2017","journal-title":"Z Geburtshilfe Neonatol."},{"issue":"10","key":"2022012716232835400_B23","doi-asserted-by":"crossref","first-page":"e229481","DOI":"10.1136\/bcr-2019-229481","article-title":"Congenital thrombotic thrombocytopenic purpura presenting in adulthood with recurrent cerebrovascular events","volume":"12","author":"Tenison","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"2","key":"2022012716232835400_B24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2003-04-1346","article-title":"Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13","volume":"103","author":"Pimanda","year":"2004","journal-title":"Blood."},{"issue":"2","key":"2022012716232835400_B25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3324\/haematol.13524","article-title":"The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura","volume":"94","author":"Palla","year":"2009","journal-title":"Haematologica."},{"issue":"10","key":"2022012716232835400_B26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajh.23527","article-title":"ADAMTS13 content in plasma-derived factor VIII\/von Willebrand factor concentrates","volume":"88","author":"Peyvandi","year":"2013","journal-title":"Am J Hematol."},{"issue":"1","key":"2022012716232835400_B27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2006.06264.x","article-title":"The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura","volume":"135","author":"Scully","year":"2006","journal-title":"Br J Haematol."},{"issue":"5","key":"2022012716232835400_B28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.thromres.2014.09.006","article-title":"Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement","volume":"134","author":"Joly","year":"2014","journal-title":"Thromb Res."},{"issue":"6","key":"2022012716232835400_B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)."},{"issue":"16","key":"2022012716232835400_B30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood-2018-04-841247","article-title":"Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow","volume":"132","author":"Ford","year":"2018","journal-title":"Blood."},{"issue":"21","key":"2022012716232835400_B31","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2019000601","article-title":"Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome","volume":"3","author":"Fujimura","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"2022012716232835400_B32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2018.04.051","article-title":"Cardiopulmonary adaptation during first day of life in human neonates","volume":"200","author":"Jain","year":"2018","journal-title":"J Pediatr."},{"issue":"12","key":"2022012716232835400_B33","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood."},{"key":"2022012716232835400_B34","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1038\/ncomms8858","article-title":"Flow-driven assembly of VWF fibres and webs in in\u00a0vitro microvessels","volume":"6","author":"Zheng","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"2022012716232835400_B35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc1905426","article-title":"Caplacizumab therapy without plasma exchange for acquired thrombotic thrombocytopenic purpura","volume":"381","author":"Chander","year":"2019","journal-title":"N Engl J Med."},{"issue":"11","key":"2022012716232835400_B36","doi-asserted-by":"crossref","first-page":"E316","DOI":"10.1002\/ajh.25964","article-title":"Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura","volume":"95","author":"Kasht","year":"2020","journal-title":"Am J Hematol."},{"issue":"7","key":"2022012716232835400_B37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/apm.12833","article-title":"Maternal vascular malperfusion of the placental bed","volume":"126","author":"Ernst","year":"2018","journal-title":"APMIS."},{"issue":"10","key":"2022012716232835400_B38","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ajh.25914","article-title":"Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13\u2009weeks\u2019 gestation","volume":"95","author":"Avery","year":"2020","journal-title":"Am J Hematol."},{"issue":"1","key":"2022012716232835400_B39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/asheducation-2015.1.644","article-title":"Syndromes of thrombotic microangiopathy associated with pregnancy","volume":"2015","author":"George","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"11","key":"2022012716232835400_B40","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury-Stewart","year":"2014","journal-title":"PLoS One."},{"issue":"12","key":"2022012716232835400_B41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/ajh.26328","article-title":"Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist","volume":"96","author":"Perez Botero","year":"2021","journal-title":"Am J Hematol."},{"issue":"1","key":"2022012716232835400_B42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jth.13186","article-title":"High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence","volume":"14","author":"von Krogh","year":"2016","journal-title":"J Thromb Haemost."},{"issue":"25","key":"2022012716232835400_B43","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood.2020009801","article-title":"Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura","volume":"137","author":"Tarasco","year":"2021","journal-title":"Blood."},{"issue":"19","key":"2022012716232835400_B44","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood."},{"key":"2022012716232835400_B45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jha2.29","article-title":"Hypertension in patients with hereditary TTP","author":"Borogovac","year":"2020","journal-title":"eJHaem."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/3\/750\/1864918\/advancesadv2021005760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/3\/750\/1864918\/advancesadv2021005760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:25:55Z","timestamp":1643282755000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/3\/750\/482724\/Morbidities-and-mortality-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005760","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}